Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia
Titel:
Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia
Auteur:
Lanasa, Mark C. Andritsos, Leslie Brown, Jennifer R. Gabrilove, Janice Caligaris-Cappio, Federico Ghia, Paolo Larson, Richard A. Kipps, Thomas J. Leblond, Veronique Milligan, Donald W. Janssens, Ann Johnson, Amy J. Heerema, Nyla A. Bühler, Andreas Stilgenbauer, Stephan Devin, Jeanne Hallek, Michael Byrd, John C. Grever, Michael R.